MERTK and neoplasm: An elegant work using two immunocompetent syngeneic murine models of BCa (4T1 and E0771) has investigated how differential expression of AXL expression on tumor cells and MERTK on immune host cells could cooperate to promote immune evasion and immunosuppression (179).